Marinus Pharmaceuticals, Inc.

9 Days Left

Class Action Period:
March 17, 2021 - May 07, 2024

Lead Plaintiff Deadline:
August 05, 2024

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.

First Name

Last Name

Phone

Street Address

City

State

Zip

Shares Purchased

Purchase Date

Estimated Loss

The submission of this form does not create an attorney-client relationship.

Allegations

The filed complaint alleges that Marinus Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) defendants understated the risk of failure to meet the early-stopping criteria in the Randomized Therapy in Status Epilepticus Trial (RAISE); (2) defendants did not disclose that a possible consequence of failing to meet the early stopping criteria in the RAISE trial would be that Marinus would stop the separate Phase 3 RAISE II trial; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of Marinus purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Marinus during the relevant time frame, you have until August 05, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.